A novel pyridoindole improves the recovery of residual hearing following cochlear implantation after a single preoperative application

Author:

Arnoldner Christoph1,Nieratschker Michael1,Yildiz Erdem1ORCID,Gerlitz Matthias1,Bera Sujoy2,Gadenstaetter Anselm1,Kramer Anne-Margarethe1,Kwiatkowska Monika2ORCID,Mistrik Pavel3ORCID,Landegger Lukas1ORCID,Braun Susanne4,Schlingensiepen Reimar2,Honeder Clemens1,Rommelspacher Hans2

Affiliation:

1. Medical University of Vienna

2. AudioCure

3. MED-EL Medical Electronics

4. Med-El Electronics

Abstract

Abstract Sensorineural hearing loss (SNHL) is the most common sensory deficit worldwide. Due to the heterogeneity of causes for SNHL, effective treatment options remain scarce, creating an unmet need for novel drugs in the field of otology. Cochlear implantation (CI) currently is the only established method to restore hearing function in profound SNHL and deaf patients. The cochlear implant bypasses the non-functioning sensory hair cells (HCs) and electrically stimulates the neurons of the cochlear nerve. CI also benefits patients with residual hearing by combined electrical and auditory stimulation. However, the insertion of an electrode array into the cochlea induces an inflammatory response, characterized by the expression of pro-inflammatory cytokines, upregulation of reactive oxygen species, and apoptosis and necrosis of HCs, putting residual hearing at risk. Here, we characterize the effects of the small molecule AC102, a pyridoindole, for its protective effects on residual hearing in CI. We show that AC102 significantly preserves hearing thresholds across the whole cochlea and confines the cochlear trauma to the directly mechanically injured area. In addition, AC102 significantly preserves auditory nerve fibers and inner HC synapses throughout the whole cochlea. AC102s effects are likely elicited during the inflammatory phase of electrode insertion trauma (EIT) and mediated by anti-apoptotic and anti-inflammatory properties, as uncovered by an in vitro assay of ethanol induced apoptosis and evaluation of mRNA expression of pro-inflammatory cytokines in an organotypic ex vivo model of EIT. The results in this study highlight AC102 as a promising compound for the attenuation of EIT during CI. Moreover, as the inflammatory response in cochlear implantation shares similarities to other etiologies of SNHL, a beneficial effect of AC102 can be inferred for other inner ear conditions as well.

Publisher

Research Square Platform LLC

Reference65 articles.

1. Organization WH. Deafness and hearing loss. 2018.

2. Mechanisms of sensorineural cell damage, death and survival in the cochlea;Wong AC;Front Aging Neurosci,2015

3. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss;Brock PR;N Engl J Med,2018

4. Prevention of cisplatin-induced hearing-loss by sodium thiosulfate in medulloblastoma;Harao T;Pediatr Int,2020

5. Randomized, Blinded Study Evaluating the Efficacy, Safety and Tolerability of a Single Intratympanic Dose of AC102 Compared to Oral Steroids for the Treatment of Idiopathic Sudden;AudioCure P,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3